Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Milestone Pharmaceuticals Q4 EPS $(0.40) Down From $(0.23) YoY

Milestone Pharmaceuticals (NASDAQ:MIST) reported quarterly losses of $(0.40) per share. This is a 73.91 percent decrease over losses of $(0.23) per share from the same period last year.
byBenzinga Newsdesk
March 24, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Milestone Pharmaceuticals (NASDAQ:MIST) reported quarterly losses of $(0.40) per share. This is a 73.91 percent decrease over losses of $(0.23) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

BET Launches BET Studios

By Benzinga Newsdesk
Today, 1:25 PM
BET, a unit of ViacomCBS (NASDAQ:VIAC, VIACA)))), today launched BET Studios, an unprecedented studio venture that offers equity ownership for Black content creators. Propelled by the infrastructure and

VIAC